Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

New, more reliable testing program rolled-out to hospital staff to curb Covid transmission rates

Frontline staff at Norfolk and Norwich University Hospitals are among the first in the country to benefit from the rollout of more accurate saliva tests in a bid to curb Covid transmission rates.

25 Feb 2021

UC San Diego receives $33 million from NIH for five COVID-19 diagnostic projects

University of California San Diego was awarded five Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health, totaling nearly $33 million over four years.

25 Feb 2021

SARS-CoV-2 ORF7a mutation limits host immune suppression, finds study

Researchers have identified a high variability in the C-terminal end of ORF7a in SARS-CoV-2 sequences collected from around the globe. They noted that mutations result in a defective suppression of interferon and lowered replication rate.

25 Feb 2021

Have a case of a Covid variant? No one is going to tell you

Covid-19 infections from variant strains are quickly spreading across the U.S., but there's one big problem: Lab officials say they can't tell patients or their doctors whether someone has been infected by a variant.

25 Feb 2021

SNX-5422 could make an effective COVID-19 prophylactic, says study

SNX-5422 is a heat shock protein 90 (Hsp90) inhibitor currently undergoing clinical trials as a cancer therapeutic. A recent study examines the applicability of repurposing the drug towards severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication inhibition.

25 Feb 2021

Covid vaccine websites violate disability laws, create inequity for the blind

Many Covid vaccination registration and information websites at the federal, state and local levels violate disability rights laws, hindering the ability of blind people to sign up for a potentially lifesaving vaccine, a KHN investigation has found.

25 Feb 2021

Research shows effective strategy to target the SARS-CoV-2 spike protein

The virus that causes COVID-19 belongs to the family of coronaviruses, "corona" referring to the spikes on the viral surface. These spikes are not static - to infect cells, they change shapes.

25 Feb 2021

International cooperation is key to get equal access to COVID-19 vaccines

Almost 130 countries are yet to receive a single COVID-19 vaccine dose, as ten high-income countries secure the majority.

25 Feb 2021

Study reveals molecular details of SARS-CoV-2 interactions with human cells

In order to infect cells, SARS-CoV-2, the virus that causes COVID-19, needs to insert itself into the membrane of human cells. New molecular models show what parts of SARS-CoV-2 are critical for that interaction, revealing new potential drug targets.

25 Feb 2021

Study reports lasting immune response in convalescent COVID-19 patients

Researchers report the cellular immune response of convalescent patients in Germany, who recovered from mild or moderate infection compared to that of healthy people with no history of COVID-19.

25 Feb 2021

Study addresses COVID-19 pandemic concerns and guidelines for increasing food safety

A team of researchers from the United States Department of Agriculture examined how the COVID-19 pandemic has changed food practices and safety protocols for workers in food-processing plants.

25 Feb 2021

COVID-19 Antigen Self-Test from Siemens Healthineers receives special approval in Germany for self-use by laypeople

Siemens Healthineers announced today that the CLINITEST Rapid COVID-19 Antigen Self-Test has received limited special approval from the Federal Office for Drugs and Medical Devices.

From Siemens Healthineers 25 Feb 2021

Anti-phospholipid antibodies in severely ill patients not distinctive to COVID-19, says study

A new study by researchers at the University of Toronto and the University of Calgary in Canada indicates that the presence of these antibodies correlates with more severe COVID-19 symptoms and signs.

25 Feb 2021

AI-mediated analysis of vaccinated patients affirms safety of SARS-CoV-2 vaccines

A new study provides a timely answer to many of these fears, by reporting on the results of an analysis of over 31,000 vaccine recipients with respect to immediate adverse effects, reported within 21 days, of the first and/or second doses of the vaccine.

25 Feb 2021

Study of children hospitalized with COVID-19 shows 2% mortality

The COVID-19 pandemic caused by SARS-CoV-2 has been observed to be less serious in infants and children. However, this age group is also subject to certain complications following infection. A new study describes the findings of an observational study of children hospitalized with SARS-CoV-2 infection in several different hospitals across three countries.

25 Feb 2021

Neuroinvasiveness of SARS-CoV-2 shown by viral RNA and inflammation in the brain

A new study describes the results of a macaque study that showed the development of neurological features of inflammation, following infection by SARS-CoV-2.

25 Feb 2021

Study explores individual differences of SARS-CoV-2 infection in ACE2-expressing stem cells

The clinical phenotype of COVID-19, caused by SARS-CoV-2, is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor’s genetic information. Researchers use a panel of iPSCs from over 500 individuals. The researchers preferred undifferentiated iPSCs to reduce the time required to differentiate them, especially since infection is not always reliable.

25 Feb 2021

Novel single-particle digital assay using plasmonic nanobubbles

An interdisciplinary team from the University of Texas applied DIAMOND to the respiratory syncytial virus (RSV) diagnostics and demonstrated that DIAMOND is 150 times more sensitive than commercial lateral flow assays. They found that the measurements are completed within 2 minutes. The results of this study are published on the medRxiv* preprint server.

25 Feb 2021

Travel bans are effective only in the first phases of pandemic

Travel bans have been key to efforts by many countries to control the spread of COVID-19. But new research aimed at providing a decision support system to Italian policy makers, recently published in the Journal of the Royal Society Interface, suggests that reducing individual activity (i.e., social distancing, closure of non-essential business, etc.) is far superior in controlling the dissemination of Sars-CoV-2, the virus that causes COVID-19.

25 Feb 2021

High expression of ACE2 receptors in developing ovaries increases SARS-CoV-2 risk

A team of scientists from China collaborated to find if SARS-CoV-2 could also infect the ovary at different developmental stages.

25 Feb 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

New, more reliable testing program rolled-out to hospital staff to curb Covid transmission rates

UC San Diego receives $33 million from NIH for five COVID-19 diagnostic projects

SARS-CoV-2 ORF7a mutation limits host immune suppression, finds study

Have a case of a Covid variant? No one is going to tell you

SNX-5422 could make an effective COVID-19 prophylactic, says study

Covid vaccine websites violate disability laws, create inequity for the blind

Research shows effective strategy to target the SARS-CoV-2 spike protein

International cooperation is key to get equal access to COVID-19 vaccines

Study reveals molecular details of SARS-CoV-2 interactions with human cells

Study reports lasting immune response in convalescent COVID-19 patients

Study addresses COVID-19 pandemic concerns and guidelines for increasing food safety

COVID-19 Antigen Self-Test from Siemens Healthineers receives special approval in Germany for self-use by laypeople

Anti-phospholipid antibodies in severely ill patients not distinctive to COVID-19, says study

AI-mediated analysis of vaccinated patients affirms safety of SARS-CoV-2 vaccines

Study of children hospitalized with COVID-19 shows 2% mortality

Neuroinvasiveness of SARS-CoV-2 shown by viral RNA and inflammation in the brain

Study explores individual differences of SARS-CoV-2 infection in ACE2-expressing stem cells

Novel single-particle digital assay using plasmonic nanobubbles

Travel bans are effective only in the first phases of pandemic

High expression of ACE2 receptors in developing ovaries increases SARS-CoV-2 risk

Industry Focus eBook: Infectious diseases eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook: Infectious diseases eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in